// App-Quantinova.ai

PB1477 : Severe Platelet Dysfunction in Patient with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) after Tyrosine Kinase Inhibitor (TKI) Therapy

Researchers

Presenter

  • M.R. Cozzi

Principal Investigators

  • M. Battiston

  • M. Turetta

  • A. Steffan

  • S. Crestani

Medical Centers

  • Centro di Riferimento Oncologico (CRO), IRCCS, Immunopatologia e Biomarcatori Oncologici, Aviano, Italy

  • Centro di Riferimento Oncologico(CRO), IRCCS, Trattamento di Cellule Staminali per le Terapie Cellulari, Aviano, Italy

  • Centro di Riferimento Oncologico (CRO), IRCCS, Oncoematologia Trapianti Emopoietici e Terapie Cellulari, Aviano, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Philadelphia chromosome–positive (Ph+) ALL

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved